Full Text
HPR83 China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards

Abstract

Authors

Yuxia Wu Xuan Mo Jingyu Zhao Jian Ming Jun Liu Tian Wei Wei Chen

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×